Inventor
HOLMS JAMES H
US17 patents
⚠️ This page may combine multiple inventors who share the name “HOLMS JAMES H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
11 patentsUS6294573B1Sep 25, 2001
Reverse hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB131 citations97
US5952320ASep 14, 1999
Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
ABBOTT LAB34 citations92
US5112848AMay 12, 1992
Furan and pyrrole containing lipoxygenase inhibiting compounds
ABBOTT LAB38 citations92
US4992464AFeb 12, 1991
Heteroaryl N-hydroxy amides and ureas with polar substituents as 5-lipoxygenase inhibitors
ABBOTT LAB26 citations92
US5124342AJun 23, 1992
4-hydroxythiazoles as 5-lipoxygenase inhibitors
ABBOTT LAB53 citations91
US5665777ASep 9, 1997
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB24 citations90
US5026729AJun 25, 1991
Lipoxygenase inhibiting compounds
ABBOTT LAB10 citations73
US5985911ANov 16, 1999
C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
ABBOTT LAB10 citations72
US5459152AOct 17, 1995
Platelet activating factor antagonists
ABBOTT LAB8 citations72
US7468371B2Dec 23, 2008
Tricyclic pyrazole kinase inhibitors
ABBOTT LAB4 citations60
US7129260B2Oct 31, 2006
Isoindolinone kinase inhibitors
ABBOTT LAB1 citations51
ABBVIE INC
4 patentsUS9321764B2Apr 26, 2016
Dihydro-pyrrolopyridinone inhibitors
ABBVIE INC3 citations72
US9296741B2Mar 29, 2016
Bromodomain inhibitors
ABBVIE INC7 citations72
US9561231B2Feb 7, 2017
Pyridinone and pyridazinone derivatives
ABBVIE INC4 citations71
US10035800B2Jul 31, 2018
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
ABBVIE INC3 citations70